.svg){kind=small}
Richmond Pharmacology is excited to announce that Dr. Jörg Taubel, Dr.Ulrike Lorch, Nobuo Ittetsu, and Minoru Takada will be attending BioJapan 2024in Yokohama. As Asia’s premier partnering event for the global biotechnologyindustry, BioJapan offers an unparalleled opportunity to engage with leaders inlife sciences, explore new business opportunities, and discuss the latestinnovations in biotechnology. The event will feature networking sessions,exhibitions, and one-on-one partnering meetings, making it a crucial gatheringfor industry professionals.
For more details, visit the BioJapan 2024 page.
-min.jpg)
.jpg)
Latest news
Richmond Appoints Lisa Campbell as Director of Regulatory Strategy
April 23, 2025
Richmond Pharmacology is pleased to announce the appointment of Lisa Campbell as Director of Regulatory Strategy
Read moreVon Willebrand Disease – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol
April 2, 2025
Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...
Read moreEvents
Swiss Biotech Day 2025
5–6 May 2025
Richmond Pharmacology is pleased to confirm our participation at Swiss Biotech Day 2025
View event
